Last update 31 May 2025

BM-1901

Overview

Basic Info

Drug Type
CAR-M
Synonyms
BM 1901, BM1901, RR-M01
Target
HER2
Action
modulators
Mechanism
HER2 modulators(Receptor tyrosine-protein kinase erbB-2 modulators)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseUrogenital Diseases+ [2]
Active Indication
Recurrent ovarian cancerRefractory Ovarian CarcinomaBreast Cancer+ [3]
Inactive Indication-
Originator Organization-
Active Organization
Kunshi Biotechnology (Suzhou) Co., Ltd.Kunshi Biotechnology (Shenzhen) Co. Ltd.Kunshi Biotechnology (Shenzhen) Co. Ltd.
Inactive Organization-
License Organization
Kunshi Biotechnology (Shenzhen) Co. Ltd.Kunshi Biotechnology (Shenzhen) Co. Ltd.Guangzhou Boteng Biomedical Technology Co., Ltd.Guangzhou Boteng Biomedical Technology Co., Ltd.
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with BM-1901
Login to view more data
100 Translational Medicine associated with BM-1901
Login to view more data
100 Patents (Medical) associated with BM-1901
Login to view more data
100 Deals associated with BM-1901
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Recurrent ovarian cancerPhase 1
China
Kunshi Biotechnology (Suzhou) Co., Ltd.
26 Jan 2024
Refractory Ovarian CarcinomaPhase 1
China
Kunshi Biotechnology (Suzhou) Co., Ltd.
26 Jan 2024
Breast CancerPreclinical
China
Kunshi Biotechnology (Suzhou) Co., Ltd.
01 Dec 2024
Pancreatic CancerPreclinical
China
Kunshi Biotechnology (Suzhou) Co., Ltd.
01 Dec 2024
Stomach CancerPreclinical
China
Kunshi Biotechnology (Suzhou) Co., Ltd.
01 Dec 2024
HER2 Positive Solid TumorsPreclinical
China
Kunshi Biotechnology (Shenzhen) Co. Ltd.Kunshi Biotechnology (Shenzhen) Co. Ltd.
19 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free